Oncologynurseadvisor - oncologynurseadvisor.com - Latest articles from ONA
General Information:
Latest News:
Pretreating aggressive lymphoma with targeted therapy improves chemo effectiveness 27 Aug 2013 | 06:00 pm
Patients with diffuse large B-cell lymphoma, which often relapses and kills within 2 years, experienced a remission of their cancer and stayed disease-free as long as 28 months after taking a commerci...
Interleukin-2 extends life in melanoma brain metastases 27 Aug 2013 | 04:00 pm
Researchers are suggesting that high-dose interleukin-2 (HD IL-2) therapy should be considered as a treatment option in patients with melanoma brain metastases who are otherwise eligible for therapy, ...
More invasive breast cancer surgery comes with growing use of MRIs 27 Aug 2013 | 12:00 am
Heavy use of magnetic resonance imaging (MRI) may be leading to unnecessary breast removal in older women with breast cancer, according to a new study.
New therapy strategy for breast cancer that has spread to the brain 26 Aug 2013 | 09:41 pm
Cellular therapy and gene therapy have been successfully combined in a mouse model to develop a viable treatment strategy for breast cancer that has spread to a patient's brain.
Valchlor Topical Gel Approved for Early Stage Cutaneous T-cell Lymphoma 26 Aug 2013 | 09:09 pm
Valchlor topical gel has been granted marketing approval for the treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma (CTCL) in patients who have received prior skin-directed ...
Mirvaso Topical Gel Approved for Facial Erythema of Rosacea 26 Aug 2013 | 09:03 pm
The FDA has approved Galderma's Mirvaso (brimonidine) topical gel for the topical treatment of the facial erythema associated with rosacea in adults 18 years or older.
Tomosynthesis reduces recall rate in breast screening 26 Aug 2013 | 04:00 pm
Combining tomosynthesis with digital mammography lowered recall rates by 30% among women being screened for breast cancer, with the greatest reductions seen in patients younger than age 50 years and i...
Tamoxifen halves breast cancer risk in high-risk women 24 Aug 2013 | 12:00 am
A global study of women with inherited mutations in BRCA1 or BRCA2 found that tamoxifen could halve the risk for breast cancer in the contralateral (opposite-side) breast in these high-risk women.
Pennsaid 2% NDA Under Review for Osteoarthritis of the Knee 23 Aug 2013 | 09:28 pm
DECK: The FDA has accepted for filing the New Drug Application (NDA) for Pennsaid (diclofenac sodium topical solution; Mallinckrodt) 2% w/w in the treatment for pain associated with osteoarthritis of ...
Ortiga Supplement Contains Hidden NSAID 23 Aug 2013 | 07:20 pm
The FDA is advising against the purchase and use of Ortiga after it was found to contain diclofenac, a prescription NSAID.
